Our study highlights that fractalkine should be included in future RV and asthma studies to further our understanding for the specific role and impact of this dual chemokine and adhesion factor in recruiting circulating immune cells to sites of infection and to consider the potential effect of the fractalkine-chemotaxis axis on RV-induced symptom severity in asthma. The gene discussed is CX3CL1; the disease is infection.